VAX102

BIOLOGICAL3 trials

Sponsors

VaxInnate Corporation

Conditions

Influenza

Phase 1

Study to Investigate the Immune Response to Two Doses of VAX102 Healthy Adults

CompletedNCT00921206

VaxInnate CorporationInfluenza

Start: 2009-06-30End: 2009-12-31Updated: 2014-09-23

Safety of VAX102 Vaccine Given With Seasonal Flu Vaccine in Healthy Adults

CompletedNCT00921973

VaxInnate CorporationInfluenza

Start: 2009-06-30End: 2009-09-30Updated: 2014-09-23

Comparative Safety and Immunogenicity of 1.0 µg Intramuscular (i.m.) and 2.0 µg Subcutaneous (s.c.) Dosing With VAX102 (M2e-flagellin) Universal Influenza Vaccine in Healthy Adults

CompletedNCT00921947

VaxInnate CorporationInfluenza

Start: 2009-06-30End: 2009-08-31Updated: 2011-08-24

Related Papers

Immunopotentiation of trivalent influenza vaccine when given with VAX102, a recombinant influenza M2e vaccine fused to the TLR5 ligand flagellin.

2010-12-2861 citations